Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic Testing

被引：138

作者：

Placencio, Veronica R. ^{[1
,2
]}

DeClerck, Yves A. ^{[1
,2
,3
]}

机构：

[1] Univ So Calif, Dept Pediat, Div Hematol Oncol & Blood & Bone Marrow Transplan, Los Angeles, CA 90089 USA

[2] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA

[3] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA

来源：

CANCER RESEARCH | 2015年 / 75卷 / 15期

基金：

美国国家卫生研究院;

关键词：

FIBROSARCOMA CELLS; PAI-1; INHIBITOR; BREAST-CANCER; TUMOR-GROWTH; WILD-TYPE; UROKINASE; TYPE-1; ANGIOGENESIS; DEFICIENT; BINDING;

D O I：

10.1158/0008-5472.CAN-15-0876

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Despite its function as an inhibitor of urokinase and tissue-type plasminogen activator (PA), PA inhibitor-1 (PAI-1) has a paradoxical protumorigenic role in cancer, promoting angiogenesis and tumor cell survival. In this review, we summarize preclinical evidence in support of the protumorigenic function of PAI-1 that has led to the testing of small-molecule PAI-1 inhibitors, initially developed as antithrombotic agents, in animal models of cancer. The review discusses the challenges and the opportunities that lay ahead to the development of efficacious and nontoxic PAI-1 inhibitors as anticancer agents. (C) 2015 AACR.

引用

页码：2969 / 2974

页数：6

共 50 条

[21] Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin
Luo, M.
Ji, Y.
Luo, Y.
Li, R.
Fay, W. P.
Wu, J.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (12) : 2451 - 2460
[22] Design and synthesis of oxadiazolidinediones as inhibitors of plasminogen activator inhibitor-1
Gopalsamy, A
Kincaid, SL
Ellingboe, JW
Groeling, TM
Antrilli, TM
Krishnamurthy, G
Aulabaugh, A
Friedrichs, GS
Crandall, DL
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (13) : 3477 - 3480
[23] REVERSIBLE INTERACTIONS BETWEEN PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
MIMURO, J
KANEKO, M
MURAKAMI, T
MATSUDA, M
SAKATA, Y
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1160 (03) : 325 - 334
[24] Thrombomodulin and Plasminogen Activator Inhibitor-1 Expression in Recurrent Miscarriages
Papamitsou, Theodora
Toskas, Alexandros
Papadopoulo, Kyriaki
Economou, Zinon
Sioga, Antonia
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2016, 38 (06): : 350 - 356
[25] Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis
Alotaibi, Fahad T.
Peng, Bo
Klausen, Christian
Lee, Anna F.
Abdelkareem, Amr O.
Orr, Natasha L.
Noga, Heather
Bedaiwy, Mohamed A.
Yong, Paul J.
PLOS ONE, 2019, 14 (07):
[26] Circulating plasminogen activator inhibitor-1 activity: a biomarker for resectable non-small cell lung cancer?
Sotiropoulos, George P.
Kotopouli, Marianna
Karampela, Irene
Christodoulatos, Gerasimos-Socrates
Antonakos, Georgios
Marinou, Ioanna
Vogiatzakis, Evaggelos
Lekka, Antigoni
Papavassiliou, Athanasios G.
Dalamaga, Maria
JOURNAL OF BUON, 2019, 24 (03): : 943 - 954
[27] Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells
Kang, JiHoon
Kim, Wanyeon
Kwon, TaeWoo
Youn, HyeSook
Kim, Joong Sun
Youn, BuHyun
ONCOTARGET, 2016, 7 (17) : 23961 - 23974
[28] Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer
Gillespie, Earl
Leeman, Susan E.
Watts, Luisa A.
Coukos, Jennifer A.
O'Brien, Michael J.
Cerda, Sandra R.
Farraye, Francis A.
Stucchi, Arthur F.
JOURNAL OF CROHNS & COLITIS, 2013, 7 (05) : 403 - 411
[29] Characterization of a Novel Class of Polyphenolic Inhibitors of Plasminogen Activator Inhibitor-1
Cale, Jacqueline M.
Li, Shih-Hon
Warnock, Mark
Su, Enming J.
North, Paul R.
Sanders, Karen L.
Puscau, Maria M.
Emal, Cory D.
Lawrence, Daniel A.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (11) : 7892 - 7902
[30] Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling
Stefansson, S
McMahon, GA
Petitclerc, E
Lawrence, DA
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (19) : 1545 - 1564

← 1 2 3 4 5 →